JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB78429

Anti-CCR6 antibody

3

(2 Reviews)

|

(15 Publications)

Rabbit Polyclonal CCR6 antibody. Suitable for WB and reacts with Rat, Human samples. Cited in 15 publications. Immunogen corresponding to Synthetic Peptide within Human CCR6 aa 350 to C-terminus.

View Alternative Names

CD196, CKRL3, CMKBR6, GPR29, STRL22, CCR6, C-C chemokine receptor type 6, C-C CKR-6, CC-CKR-6, CCR-6, Chemokine receptor-like 3, DRY6, G-protein coupled receptor 29, GPR-CY4, LARC receptor, CKR-L3, GPRCY4

1 Images
Western blot - Anti-CCR6 antibody (AB78429)
  • WB

Supplier Data

Western blot - Anti-CCR6 antibody (AB78429)

All lanes:

Western blot - Anti-CCR6 antibody (ab78429) at 0.5 µg/mL

Lane 1:

Rat Liver Tissue Lysate

Lane 2:

SW620 Cell Lysate

Lane 3:

CEM Cell Lysate

Predicted band size: 42 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Rat, Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human CCR6 aa 350 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P51684

Specificity

No cross reactivity with other proteins.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.5 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.5 µg/mL", "WB-species-notes": "<p></p>" }, "Dog": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
Preservative: 0.025% Sodium azide Constituents: 2% Trehalose, 0.45% Sodium chloride, 0.1% Disodium hydrogenorthophosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CCR6 also known as CD196 is a chemokine receptor with a molecular mass of approximately 44 kDa. This protein is primarily expressed on the surface of various immune cells including T cells B cells and dendritic cells. Through its interaction with its only known ligand CCL20 also known as MIP-3α CCR6 mediates chemotaxis which guides the targeted migration of cells to sites of inflammation or injury. In murine models (mouse) CCR6 expression helps researchers examine immune responses in vivo and its presence is detected using recombinant proteins or antibodies specific for CCR6 such as 'CCR6 antibodies' with techniques including flow cytometry utilizing labels like CCR6-APC or CCR6-fluorochrome.
Biological function summary

CCR6 plays an essential role in the regulation of immune responses and maintaining mucosal immunity. It is involved in the recruitment of Th17 cells and dendritic cells to inflamed tissues which plays a critical role in initiating and sustaining immune responses. While CCR6 operates primarily as a standalone receptor its engagement influences diverse cellular functions linked to immune surveillance and tolerance. This receptor's expression on lymphoid tissue inducer cells indicates its relevance in the formation of secondary lymphoid organs and in dynamic interactions within the immune system.

Pathways

CCR6 is a significant component in pathways related to immune cell trafficking and inflammatory responses particularly the MAPK/ERK pathway and the JAK/STAT pathway. In these pathways CCR6 often interacts with related proteins such as CCL20 and other chemokine receptors facilitating cellular migration and activation processes. These interactions underpin the migration of regulatory T cells and B cells which modulate inflammation and affect pathogen clearance ensuring a controlled immune response.

CCR6 has links to conditions such as autoimmune diseases with rheumatoid arthritis and inflammatory bowel disease being notable examples. In rheumatoid arthritis the dysregulated expression of CCR6 attracts Th17 cells into synovial tissues promoting inflammation. Meanwhile inflammatory bowel disease shows a similar pattern of CCR6-mediated chemotaxis that encourages Th17 cell recruitment. In these contexts CCR6 cooperates with other immune mediators like CCL20 to perpetuate disease-related inflammatory processes highlighting its potential as a therapeutic target in immune modulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor for the C-C type chemokine CCL20 (PubMed : 9169459). Binds to CCL20 and subsequently transduces a signal by increasing the intracellular calcium ion levels (PubMed : 20068036). Although CCL20 is its major ligand it can also act as a receptor for non-chemokine ligands such as beta-defensins (PubMed : 25585877). Binds to defensin DEFB1 leading to increase in intracellular calcium ions and cAMP levels. Its binding to DEFB1 is essential for the function of DEFB1 in regulating sperm motility and bactericidal activity (PubMed : 25122636). Binds to defensins DEFB4 and DEFB4A/B and mediates their chemotactic effects (PubMed : 20068036). The ligand-receptor pair CCL20-CCR6 is responsible for the chemotaxis of dendritic cells (DC), effector/ memory T-cells and B-cells and plays an important role at skin and mucosal surfaces under homeostatic and inflammatory conditions, as well as in pathology, including cancer and various autoimmune diseases. CCR6-mediated signals are essential for immune responses to microbes in the intestinal mucosa and in the modulation of inflammatory responses initiated by tissue insult and trauma (PubMed : 21376174). CCR6 is essential for the recruitment of both the pro-inflammatory IL17 producing helper T-cells (Th17) and the regulatory T-cells (Treg) to sites of inflammation. Required for the normal migration of Th17 cells in Peyers-patches and other related tissue sites of the intestine and plays a role in regulating effector T-cell balance and distribution in inflamed intestine. Plays an important role in the coordination of early thymocyte precursor migration events important for normal subsequent thymocyte precursor development, but is not required for the formation of normal thymic natural regulatory T-cells (nTregs). Required for optimal differentiation of DN2 and DN3 thymocyte precursors. Essential for B-cell localization in the subepithelial dome of Peyers-patches and for efficient B-cell isotype switching to IgA in the Peyers-patches. Essential for appropriate anatomical distribution of memory B-cells in the spleen and for the secondary recall response of memory B-cells (By similarity). Positively regulates sperm motility and chemotaxis via its binding to CCL20 (PubMed : 23765988).
See full target information CCR6

Publications (15)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in cellular and infection microbiology 11:535352 PubMed34277460

2021

Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Jennifer P Bharucha,Lingling Sun,Wuyuan Lu,Suzanne Gartner,Alfredo Garzino-Demo

Frontiers in oncology 11:667174 PubMed34178651

2021

Tongue Cancer Cell-Derived CCL20 Induced by Interaction With Macrophages Promotes CD163 Expression on Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Manabu Shigeoka,Yu-Ichiro Koma,Takayuki Kodama,Mari Nishio,Masaya Akashi,Hiroshi Yokozaki

Scientific reports 10:21342 PubMed33288848

2020

Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Kung-Chao Chang,Ruo-Yu Chen,Yu-Chu Wang,Liang-Yi Hung,L Jeffrey Medeiros,Ya-Ping Chen,Tsai-Yun Chen,Jui-Chu Yang,Po-Min Chiang

Molecular medicine reports 22:1317-1324 PubMed32627009

2020

Age‑dependent alterations in the immunoreactivity of macrophage inflammatory protein‑3α and its receptor CCR6 in the gerbil hippocampus.

Applications

Unspecified application

Species

Unspecified reactive species

Ji Hyeon Ahn,Joon Ha Park,Tae-Kyung Lee,Go Eun Yang,Myoung Cheol Shin,Jun Hwi Cho,Moo-Ho Won,Choong-Hyun Lee

Frontiers in pharmacology 11:45 PubMed32116720

2020

Alleviation of Synovial Inflammation of Juanbi-Tang on Collagen-Induced Arthritis and TNF-Tg Mice Model.

Applications

Unspecified application

Species

Unspecified reactive species

Tengteng Wang,Qingyun Jia,Tao Chen,Hao Yin,Xiaoting Tian,Xi Lin,Yang Liu,Yongjian Zhao,Yongjun Wang,Qi Shi,Chenggang Huang,Hao Xu,Qianqian Liang

Oncology reports 42:1946-1956 PubMed31545478

2019

lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Wei,Xiaoliang Zhao,Jianquan Zhu,Lianmin Zhang,Yulong Chen,Bin Zhang,Yue Li,Meng Wang,Zhenfa Zhang,Changli Wang

Brain research bulletin 152:27-34 PubMed31299319

2019

The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T Itpr3/J mouse model of autism.

Applications

Unspecified application

Species

Unspecified reactive species

Sheikh F Ahmad,Mushtaq A Ansari,Ahmed Nadeem,Saleh A Bakheet,Ahmed Z Alanazi,Sary Alsanea,Homood M As Sobeai,Mashal M Almutairi,Hafiz M Mahmood,Sabry M Attia

Journal of neuroinflammation 16:115 PubMed31151410

2019

CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies.

Applications

Unspecified application

Species

Unspecified reactive species

Mahasweta Das,Xiaolan Tang,Jung Yeon Han,Karthick Mayilsamy,Elspeth Foran,Manas R Biswal,Radouil Tzekov,Shyam S Mohapatra,Subhra Mohapatra

Viruses 10: PubMed30249047

2018

Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR) That Is Blocked by Interleukin-10.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Chen,Mee Yong Bartee,Jordan R Yaron,Liying Liu,Liqiang Zhang,Donghang Zheng,Ian B Hogue,Whitney L Bullard,Scott Tibbetts,Alexandra R Lucas

Biological research 51:12 PubMed29788995

2018

In vitro chemokine (C-C motif) receptor 6-dependent non-inflammatory chemotaxis during spermatogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Ruiying Diao,Xueyong Cai,Lu Liu,Lihua Yang,YongGang Duan,Zhiming Cai,Yaoting Gui,Lisha Mou
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com